Transtek(SZ:300562) Xin Lang Cai Jing·2025-10-28 02:35Core Insights - The company reported a total revenue of 757 million yuan for Q3 2025, with a net profit attributable to shareholders of 65.68 million yuan and a net cash inflow from operating activities of 104 million yuan [1]. Financial Performance - The latest asset-liability ratio stands at 30.10% [3]. - The gross profit margin is 35.59%, which is a decrease of 0.67 percentage points compared to the same period last year [3]. - The return on equity (ROE) is reported at 6.48% [3]. - The diluted earnings per share (EPS) is 0.30 yuan [3]. - The total asset turnover ratio is 0.52 times, while the inventory turnover ratio is 5.99 times [3]. Shareholder Structure - The number of shareholders is 23,900, with the top ten shareholders holding a total of 77.11 million shares, accounting for 35.28% of the total share capital [3]. - The top shareholders include: 1. Pan Weichao - 30.51% 2. Pan Zhigang - 0.91% 3. Sun Hao - 0.72% 4. Wang Guochang - 0.57% 5. Industrial and Commercial Bank of China - 0.55% 6. China Merchants Bank - 0.43% 7. China Construction Bank - 0.43% 8. Fang Yizhong - 0.41% 9. Guangdong Lexin Medical Electronics Co., Ltd. - 0.34% 10. Jiang Jinqiao - 0.34% [3].